Infection of mice with francisella as an immunological model

Current Protocols in Immunology

Volumn , Issue SUPPL.93, 2011, Pages

  Conlan, J Wayne ^a   Chen, Wangxue ^a   Bosio, Catharine M ^b   Cowley, Siobhán C ^c   Elkins, Karen L ^c  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Biosafety issues; Francisella tularensis; Intracellular bacteria; Mouse models; Respiratory infection; Systemic infection

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM INFECTION; DISEASE MODEL; EAR INFECTION; EXPERIMENTAL MOUSE; FRANCISELLA TULARENSIS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SKIN INFECTION; T LYMPHOCYTE; TULAREMIA;

EID: 82355171598     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Anthony, L.S.D., Skamene, E., and Knogshavn, P.A.L. 1988. Influence of genetic background on host resistance to experimental murine tularemia. Infect. Immun. 56:2089-2093.
2. Baker, C.N., Hollis, D.G., and Thornsberry, C. 1985. Anti-microbial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J. Clin. Micro. 22:212-215.
3. Collazo, C.M., Meierovics, A.I., De Pascalis, R., Wu, T.H., Lyons, C.R., and Elkins, K.L. 2009. T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria. Infect. Immun. 77:2010-2021.
4. Cong, Y., Yu, J.J., Guentzel, M.N., Berton, M.T., Seshu, J., Klose, K.E., and Arulanandam, B.P. 2009. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge. Vaccine 27:5554-5561.
5. Dennis, D.T., Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Friedlander, A.M., Hauer, J., Layton, M., Lillibridge, S.R., McDade, J.E., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K., and Tonat, K. 2001. Tularemia as a biological weapon: Medical and public health management. JAMA 285:2763-2773.
6. Elkins, K.L., Cowley, S.C., and Bosio, C.M. 2003. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 5:132-142.
7. Elkins, K.L., Cowley, S.C., and Bosio, C.M. 2007. Innate and adaptive immunity to Francisella. Ann. N.Y. Acad. Sci. 1105:284-324.
8. Elkins, K.L., Colombini, S.M., Meierovics, A.I., Chu, M.C., Chou, A.Y., and Cowley, S.C. 2010. Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma. Microbes Infect. 12:28-36.
9. Hornick, R.B., Dawkins, A.T., Eigelsbach, H.T., and Tulis, J.J. 1966. Oral tularemia vaccine in man. Antimicrob. Agents Chemother. 6:11-14.
10. Klimpel, G.R., Eaves-Pyles, T, Moen, S.T., Taormina, J., Peterson, J.W., Chopra, A.K., Niesel, D.W., Carness, P., Haithcoat, J.L., Kirtley, M., and Nasr, A.B. 2008. Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody. Vaccine 26:6874-6882.
11. KuoLee, R., Zhao, X.,Austin, J., Harris, G.,Conlan, J.W., and Chen,W. 2007a. Mouse model of oral infection with virulent Type A Francisella tularensis. Infect Immun. 75:1651-1660.
12. KuoLee, R., Harris, G., Conlan, J.W., and Chen,W. 2007b. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. Vaccine 25:3781-3791.
13. Owen, C.R., Buker, E.O., Jellison,W.L., Lackman, D.B., and Bell, J.F. 1964. Comparative studies of Francisella tularensis and Francisella novicida. J. Bacteriol. 87:676-683.
14. + T cells and antibodies, including immunoglobulin A. Clin. Vaccine Immunol. 16:444-452.
15. Rhinehart-Jones, T.R., Fortier, A.H., and Elkins, K.L. 1994. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells. Infect Immun. 62:3129-3137.
16. Shen,H., Chen,W., and Conlan, J.W. 2004. Susceptibility of various mouse strains to systemicallyor aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen. Vaccine 22:2116-2121.
17. Sjostedt, A. 2007. Tularemia: History, epidemiology, pathogen physiology, and clinical manifestations. Ann. N.Y. Acad. Sci. 1105:1-29.
18. Wu, T.H., Hutt, J.A., Garrison, K.A., Berliba, L.S., Zhou, Y., and Lyons, C.R. 2005. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect. Immun. 73:2644-2654.